Scientific committee

§01
Khosrow Kashfi, PhD, FRSC, FRSB
Khosrow Kashfi, PhD, FRSC, FRSB
CUNY School of Medicine · New York, NY

Associate medical professor of biochemistry and pharmacology. His laboratory develops nitric oxide- and hydrogen sulfide-releasing compounds (NOSH-NSAIDs) for the prevention and treatment of colon, pancreatic, and ER-negative breast cancers.

Geeta Upadhyay, PhD
Geeta Upadhyay, PhD
Uniformed Services University · Bethesda, MD

Associate professor in the Departments of Pathology and Molecular & Cellular Biology. Her lab studies the Ly6 gene family in TGF-β signaling and immune escape, with a focus on triple-negative breast cancer and targeted therapy resistance.

Lucas Ferrari de Andrade, PhD
Lucas Ferrari de Andrade, PhD
Icahn School of Medicine at Mount Sinai · New York, NY

Associate professor in the Department of Immunology and Immunotherapy and the Precision Immunology Institute. His laboratory develops pharmacological approaches to promote natural killer (NK) cell-mediated immunity against solid tumors and hematologic malignancies.

Suresh Ambudkar, PhD
Suresh Ambudkar, PhD
National Cancer Institute / NIH · Bethesda, MD

Senior investigator studying ATP-binding cassette (ABC) drug transporters, including P-glycoprotein, and their role in multidrug resistance — with the goal of developing strategies to restore chemotherapy sensitivity.

William Gmeiner, PhD, MBA
William Gmeiner, PhD, MBA
Wake Forest University School of Medicine · Winston-Salem, NC

Professor of cancer biology whose lab studies the mechanisms by which anticancer drugs induce cell death, and designs new nucleic-acid-based therapeutics, including a novel fluoropyrimidine polymer platform.

Lee Graves, PhD
Lee Graves, PhD
University of North Carolina at Chapel Hill · Chapel Hill, NC

Professor of pharmacology researching cellular mechanisms of drug resistance in cancer, using kinome-wide proteomics to understand how cancer cells respond and adapt to targeted therapies.

Lee Graves, PhD
Hernando Lopez Bertoni
Johns Hopkins School of Medicine, Baltimore

Associate Professor at Johns Hopkins School of Medicine specializing in neuro-oncology, researching nanoparticle-delivered RNA therapeutics to target cancer stem cells in aggressive brain tumors